VANCOUVER, British Columbia and MENLO PARK, Calif., May 7, 2019 /PRNewswire/ — DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) (“DelMar” or the “Company”), a biopharmaceutical company focused on the development and commercialization of new… Read More
Top-line safety and efficacy results from an interim analysis of the initial Phase 1a/1b clinical trial of AB-506, a proprietary oral capsid inhibitor, expected in July 2019 Conference Call and… Read More
VANCOUVER, British Columbia and MENLO PARK, Calif., May 6, 2019 /PRNewswire/ — DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) (“DelMar” or the “Company”), a biopharmaceutical company focused on the development of new cancer therapies,… Read More
WARMINSTER, Pa., April 29, 2019 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, today announced that it has scheduled its first quarter financial results, conference… Read More
Onestep Laboratories, a biotech company that specializes in developing and producing raw material for immunoassay and other assays, received a China patent CN107449902, potentially for chlorine monitoring in dialysis for… Read More
